In The News
ALS News Today: ProJenX Launches, Will Develop ALS Therapy Prosetin
MEC SAB in the News: Fastest DNA sequencing technique helps undiagnosed patients find answers in mere hours
Endpoints News: Out to prove the next big I/O target, Immunitas’ chief dealmaker steps up to CEO role
FinSMEs: Immunitas Therapeutics Closes $58M in Series B Financing
Endpoints: Touting CD161 as a test case for single-cell tech, Longwood-backed Immunitas bags $58M for next-gen I/O work
Stanford Medicine: Euan Ashley Appointed the Roger W. and Joelle G. Burnell Professor of Genomics and Precision Health